Liubomyr Mykhailovych Havryshchuk

Mr. Liubomyr Mykhailovych Havryshchuk

Chemistry, Pharmaceutical Analysis and PE, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ivano-Frankivs’ka Oblast’, Ukraine
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2022 in Farmatsevtychnyi zhurnal
Verified
Journal Article
Open access
PDF file
Liubomyr Mykhailovych HavryshchukLiubomyr Mykhailovych Havryshchuk
Liubomyr Mykhailovych Havryshchuk
ВГВ. Я. Горішній
В. Я. Горішній
РЛР. Б. Лесик
Р. Б. Лесик
Dichloroacetic acid and its derivatives exhibit the properties of metabolic cytoprotectors and apoptosis inducers. Nowadays evaluation of these derivatives is being conducted regarding the induction of immunogenic cell death. Therefore, the search for new derivatives of dichloroacetic acid as potential antitumor agents has a certain perspective and may be successful for the molecular design of «drug-like» structures. The aim of the work was the development of synthetic approaches to the obtaining of dichloroacetic acid amides and the primary screening of the antitumor activity of the synthesized compounds. Synthetic studies were conducted using reagents from the companies «Merck» (Darmstadt, Germany) and «Sigma-Aldrich» (Missouri, USA). 1H NMR spectra were measured on a Varian VXR-400 instrument, and LC-MS spectra on an Agilent 1100 Series LCMS instrument. The anticancer activity of the synthesized compounds was studied according to the international scientific program of the US National Cancer Institute – DTP (Developmental Therapeutic Program). Amides were synthesized based on acylation reactions of the corresponding substituted ethylamines and aminobenzoic acids with methyldichloroacetate and dichloroacetyl chloride. The use of two methods of acylation of amines allows obtaining the target compounds with sufficient purity and satisfactory yields (44–98%). The structure and purity of the synthesized compounds were confirmed by the methods of elemental analysis, LCMS spectrometry and 1H NMR spectroscopy. It was shown that dichloroacetyl chloride and methyl dichloroacetate are effective acylating agents, which was confirmed by the synthesis of a series of amides based on substituted ethylamines and aromatic amino acids. Moderate antitumor activity of dichloroacetamides was established on some melanoma, leukemia, and renal cancer cell lines. The highest activity was observed for 4-(2,2-dichloroacetylamino)-2-hydroxybenzoic acid, against which the mitotic activity of the LOX IMV melanoma line was 45.83%. Preliminary data on the antitumor activity indicate certain prospects for the search for anticancer agents in the group of dichloroarylacetamides in comparison with alkyl amides.

19 December 2019 in Pharmacia
Verified
Journal Article
Open access
IBIryna Bilyk
Iryna Bilyk
IFIryna Fedyak
Iryna Fedyak
IIIryna Ivaniulyk Ivaniulyk
Iryna Ivaniulyk Ivaniulyk
Liubomyr Mykhailovych HavryshchukLiubomyr Mykhailovych Havryshchuk
Liubomyr Mykhailovych Havryshchuk
A comprehensive study for assessment the appointments rationality for children with meningococcal infectious (MI) in Ukraine in real clinical practice has been conducted. The doctor’s appointment sheets from 184 inpatients medical cards have been processed by the integral ABC / VEN / frequency analysis. In average, children were in the hospital (14±7) bed-days, they were granted 2908 appointments of 191 drugs by the INN. It has been established that medicine for MI etiotropic therapy took the third place in the appointments frequency. At the same time, the ABC / VEN-analysis results revealed a rational approach to pharmacotherapy.The total treatment cost was estimated at USD 25,173.59 (for one child – USD 136.81).Since currently in Ukraine inpatient children treatment is mainly provided by parents, further medical prescriptions improvement is needed in order to increase the efficiency and minimize the childrenMI therapy cost.

22 January 2026 in Research Square
Verified
Preprint
Open access
PDF file
OBOleksandr Bulbuk
Oleksandr Bulbuk
Liubomyr Mykhailovych HavryshchukLiubomyr Mykhailovych Havryshchuk
Liubomyr Mykhailovych Havryshchuk
RLRoman Lisovsky
Roman Lisovsky
OBOlena Bulbuk
Olena Bulbuk
Background The global higher education landscape is undergoing a profound transition due to the convergence of digital technologies and pedagogical theory. In medical education, large language models now demonstrate clinical reasoning capabilities comparable to those of medical students, yet faculty training remains highly inconsistent globally. In Ukraine, this challenge is compounded by wartime pressures and a high rate of «bottom-up» AI adoption (84%) among students, which is often plagued by ethical uncertainty and a lack of structured guidance. There is an urgent need to shift the educator’s role from a «transmitter of absolute truths» to a «mediator of learning» within the emerging clinician-AI-patient triad. Methods We implemented a multi-component training program at Ivano-Frankivsk National Medical University during the 2024–2025 academic year. The program included practical workshops on AI fundamentals and medical education-specific tools, individual consultations for discipline-specific AI adaptation, the development of methodological materials, and the creation of a community of practice. We tracked quantitative metrics, including the number of trained faculty, program coverage, and the development of resources, alongside qualitative assessments of AI integration into teaching practices. Results Between September 2024 and March 2025, 211 faculty members (29% of the total 732 scientific and pedagogical staff members) completed the foundational training, with participation exceeding 90% in departments such as Anatomy and Physiology. Demographic analysis revealed strong cross-generational engagement, with 34% of participants being over 50 years old. To address the resulting regulatory and ethical gaps, Ivano-Frankivsk National Medical University formally adopted a comprehensive «Policy on the Use of Artificial Intelligence Systems» in May 2025, providing a binding legal and ethical framework for AI integration. Key outputs included Ukraine’s first comprehensive methodological guide for AI in medical education, a library of 142 documented use cases, and the deployment of two custom AI assistants that achieved a user satisfaction rating of 4.3 out of 5 across 3.200 interactions. Faculty reported successful integration of AI into lecture synthesis, case-based learning, and research supervision. Conclusions This study demonstrates the feasibility of large-scale faculty AI literacy initiatives even in resource-constrained and socially disrupted contexts. Systematic training, coupled with a formal institutional policy, facilitates the fundamental transformation of medical education required for the 21st century, ensuring educators can effectively guide students in AI-augmented healthcare practice. Investment in faculty digital competencies is essential for maintaining institutional competitiveness and academic rigor in the face of rapidly advancing machine intelligence.

29 February 2024 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
Liubomyr Mykhailovych HavryshchukLiubomyr Mykhailovych Havryshchuk
Liubomyr Mykhailovych Havryshchuk
VHVolodymyr Horishny
Volodymyr Horishny
NRNadiіa Rushchak
Nadiіa Rushchak
Roman LesykRoman Lesyk
Roman Lesyk
The aim. This review aims to provide a comprehensive understanding of dichloroacetic acid derivatives. We aim to cover all aspects of these compounds, including their chemical properties, various synthesis methods, and their wide range of applications in medicinal chemistry. By exploring their diverse roles in drug development, we aim to highlight their importance and potential in shaping future pharmaceutical innovation. Materials and methods. Bibliosemantic and analytical methods are used in the research. Results. Our studies confirm the potential effectiveness of dichloroacetic acid and its derivatives in the treatment of cancer and other diseases. These compounds can induce the apoptosis process, which is the programmed cell death, and inhibit the cancer cells' growth. This is particularly effective when dichloroacetic acid and its derivatives are used in combination with other therapeutic methods, as indicated in the patents cited in our study. Dichloroacetic acid and its derivatives have also shown the ability to lower blood glucose and cholesterol levels. This indicates the possibility of their use for diabetes, hyperlipidemia, and lactic acidosis treatment. Diabetes, hyperlipidemia, and lactic acidosis are serious conditions that can lead to significant health problems. Therefore, the possibility of using dichloroacetic acid and its derivatives for the treatment of these conditions opens new perspectives in medical science. Conclusions. Our findings point to the prospects of further research in the field of new therapy methods development and the use of dichloroacetic acid derivatives as potential drugs to improve the effectiveness of cancer and other diseases treatment. We believe that these compounds have great potential for further study and may play an important role in future medical innovation

28 February 2025 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
Liubomyr Mykhailovych HavryshchukLiubomyr Mykhailovych Havryshchuk
Liubomyr Mykhailovych Havryshchuk
VHVolodymyr Horishny
Volodymyr Horishny
IIIryna Ivasechko
Iryna Ivasechko
YKYuliia Kozak
Yuliia Kozak
DMDmytro Melnyk
Dmytro Melnyk
Roman LesykRoman Lesyk
Roman Lesyk
The aim. The study aimed to synthesize and evaluate the anticancer activity of a series of 2-chloro- and 2,2-dichloroacetamides bearing thiazole scaffolds. Particular attention was paid to their cytotoxic effects, chemical properties, and action mechanisms, with a focus on glutathione S-transferase (GST) inhibition as a potential pathway for anticancer activity. Materials and methods. The compounds were synthesized using acylation reactions and characterized via 1H and 13C NMR spectroscopy as well as LC-MS. Their cytotoxicity was assessed using the MTT assay across cancer and pseudo-normal cell lines. Quantum-chemical calculations were performed using DFT, while molecular docking studies analyzed interactions with GST to explore their interaction. Results. Among the synthesized derivatives, 2-chloroacetamides exhibited significant cytotoxic activity against human acute T cell leukemia (Jurkat) and triple-negative breast cancer (MDA-MB-231) cell lines, as well as Ba/F3 cells with calreticulin mutations. In contrast, 2,2-dichloroacetamides showed negligible activity across all tested cell lines. Quantum-chemical analysis indicated that structural and electronic differences between these two compound classes likely influence their bioactivity. Molecular docking studies revealed higher binding affinities of glutathione-2-chloroacetamide conjugates to GST, compared to the reference glutathione-etacrynic acid complex, suggesting GST inhibition as a potential mechanism underlying their anticancer effects. Conclusions. The synthesized 2-chloroacetamides demonstrate promising potential as anticancer agents, likely due to their ability to form inhibitory conjugates with glutathione, thereby affecting GST activity. These findings underline the importance of further studies to optimize these compounds for therapeutic use

5 August 2026 in BMC Medical Education
Verified
Journal Article
Open access
OBOleksandr Bulbuk
Oleksandr Bulbuk
Liubomyr Mykhailovych HavryshchukLiubomyr Mykhailovych Havryshchuk
Liubomyr Mykhailovych Havryshchuk
RLRoman Lisovsky
Roman Lisovsky
OBOlena Bulbuk
Olena Bulbuk